Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Society of You

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Society of You head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 248 · Grade C

Society of You

Visit Society of You Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 66 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Society of You a bad call — it's best for readers interested in app-based follow-up who can confirm the selected medication, commitment and refund exceptions before paying. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
73
Transparency
90
72
Access Breadth
93
62
Clinical Oversight
92
75
Track Record
88
70
CoreAge RxBrief Score 94 · 66Society of You

Price, coverage & the tracker

CoreAge RxSociety of You
Brief Score94/100 (A)66/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Confirm full selected-plan quote

Semaglutide card from $149; general program banner from $99/month. Exact period, supply and commitment unconfirmed.

Compounded program described; verify the prescription and restrictive medical-ineligibility/refund exceptions.

Full price details

Compounded semaglutide program described; complete selected-plan quote unknown; medication card starts at $149 without a complete period/commitment, while general banner says from $99/month

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Confirm full selected-plan quote

Tirzepatide card from $249; full selected period, supply and commitment unconfirmed.

Branded cards are coming soon; verify the actual prescription and refund cutoffs.

Full price details

Compounded tirzepatide program described; complete selected-plan quote unknown; medication card starts at $249 without a complete period/commitment

CoverageUS only; restrictions by state, confirmed at intakeTerms advertise all fifty U.S. states; footer qualifies treatment by clinician licensing and state availability, so confirm the selected prescription
Brand-name accessNot confirmedDetailed Ozempic, Wegovy and Mounjaro cards are labeled coming soon; current branded fulfillment is not established.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Society of You: General banner starts at $99/month; named semaglutide/tirzepatide cards start at $149/$249 without a complete selected term. Confirm the total before payment.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.